An increased expression of PTK7 correlates with poor clinical outcomes in acute myeloid leukemia, esophageal squamous cell carcinoma, colorectal cancer, cervical cancer, and thyroid cancer [14,17,34,35,36]. This evidence concerns the gene PTK7 and esophageal squamous cell carcinoma.